Home > Boards > US Listed > Biotechs > Advaxis, Inc. (ADXS)

I said before the decline into the reverse

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
shub Member Profile
 
Followed By 12
Posts 1,387
Boards Moderated 0
Alias Born 04/12/11
160x600 placeholder
Advaxis and Biosight announce merger deal to create oncology focused public company Seeking Alpha - 7/6/2021 7:13:20 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/2/2021 4:31:06 PM
Advaxis Receives Notice of Delisting from Nasdaq TipRanks - 6/28/2021 9:46:13 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/25/2021 4:31:13 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/14/2021 4:16:00 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 6/14/2021 4:02:33 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 6/7/2021 4:31:30 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/4/2021 4:32:02 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/4/2021 7:30:58 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 6/4/2021 7:30:57 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 5/24/2021 4:01:23 PM
Advaxis updates early stage results for off-the-shelf immunotherapy with Keytruda in lung cancer Seeking Alpha - 5/20/2021 7:07:23 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 5/19/2021 4:30:51 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 5/13/2021 4:11:38 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 5/7/2021 4:31:19 PM
Small Company Offering and Sale of Securities Without Registration (d) Edgar (US Regulatory) - 4/28/2021 4:10:44 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/27/2021 6:06:32 AM
Advaxis shares rise after receiving milestone payment under ADXS-HER2 licensing deal Seeking Alpha - 4/26/2021 8:54:43 AM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 4/21/2021 4:31:31 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/12/2021 5:15:29 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 4/12/2021 5:10:58 PM
Advaxis proposes $20M registered direct offering Seeking Alpha - 4/12/2021 8:47:09 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/6/2021 5:29:37 PM
Advaxis to fund earl-stage ADXS-504 study for prostate cancer Seeking Alpha - 4/5/2021 8:43:20 AM
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) Edgar (US Regulatory) - 4/2/2021 4:16:18 PM
shub   Tuesday, 07/10/18 02:36:28 PM
Re: None
Post # of 107745 
I said before the decline into the reverse split that ADXS
badly needed to sink every penny into pushing through a substantial, well controlled , ph3 clinical study....Several if we could.
I later predicted that the EU application was based on inadequate info.
This has been my first serious stock investment and has been disastrously educational and very costly.
Either management has been flagrantly incompetent, willing to exploit the stockholders faith pathologically, and or repeatedly lied to us.
Both on the YMB and here, i've voiced cynicism when it was warranted and sometimes hope and enthusiasm over the years. We really were leading the immuno parade years ago.
Because of my honestly negative opinions i've been blocked, censored and even banned.
Now, all my fears have proved true!
The substantial chance to save thousands of cancer patients from agonizing deaths has been wizzed away to support management and other parasites.
I'm profoundly saddened.
Too late to wish us all goodluck.......ironyworks/shub

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences